Are angiotensin II receptor antagonists indicated in chronic heart failure?
作者信息
Komajda Michel
机构信息
Department of Cardiology, Pitie-Salpetriere Hospital, Paris, France.
出版信息
Heart Fail Monit. 2002;2(3):85-7.
PMID:12634889
Abstract
Angiotensin II type I receptor antagonists (ARAs) have been tested in two large randomized trials, Evaluation of Losartan in the Elderly II (ELITE II) and the Valsartan Heart Failure Trial (Val-HeFT), and several other large trials are ongoing in the indication of chronic heart failure (CHF). Based on the available evidence, angiotensin converting enzyme inhibitors remain the cornerstone in the treatment of CHF. However, much more information should be available in the next few years, which will provide more evidence on how to use ARAs and in which patients.
摘要
相似文献
1
Are angiotensin II receptor antagonists indicated in chronic heart failure?
Heart Fail Monit. 2002;2(3):85-7.
2
Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int. 2005 Oct;14(79):180-6.
3
Angiotensin II type 1 receptor blockers and congestive heart failure.
Circulation. 2001 Oct 9;104(15):E82.
4
Angiotensin II receptor antagonists for the treatment of heart failure: what is their place after ELITE-II and Val-HeFT?
J Renin Angiotensin Aldosterone Syst. 2001 Jun;2(2):89-92. doi: 10.3317/jraas.2001.017.
5
[ACE inhibitors and/or sartans in heart failure: is there a difference?].
Rev Med Brux. 2003 Sep;24(4):A249-52.
6
Anti-angiotensin therapy: new perspectives.
Cardiol Clin. 2007 Nov;25(4):573-80; vi-vii. doi: 10.1016/j.ccl.2007.09.003.
7
Valsartan in chronic heart failure.
N Engl J Med. 2002 Apr 11;346(15):1173-4. doi: 10.1056/NEJM200204113461516.
8
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
Congest Heart Fail. 2002 Jan-Feb;8(1):57-8.
9
[Sartan as a new therapy option. When heart failure patients cannot tolerate an ACE inhibitor].
MMW Fortschr Med. 2002 Oct 3;144(40):49.
10
Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
Am Heart J. 2004 Jul;148(1):122-8. doi: 10.1016/j.ahj.2003.12.040.
Zotero 插件